Nayapime-TZ 1125mg Injection
Marketer
Accilex Nutricorp
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Nayapime-TZ 1125mg Injection
This injectable medication, Nayapime-TZ 1125mg, combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial growth. Administration must be overseen by a qualified healthcare provider; strictly adhere to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic responses (e.g., hives, itching, swelling, respiratory distress). Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from operating vehicles if drowsiness or dizziness occurs.
Uses of Nayapime-TZ 1125mg Injection
Infections caused by bacteria
Major Benefits of Nayapime-TZ 1125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nayapime-TZ 1125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Nayapime-TZ 1125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nayapime-TZ 1125mg Injection works:
Nayapime-TZ 1125mg Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Nayapime-TZ 1125mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Nayapime-TZ (1125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Nayapime-TZ 1125mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Nayapime-TZ 1125mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Individuals with impaired kidney function should use Nayapime-TZ 1125mg Injection cautiously. Dosage modification of Nayapime-TZ 1125mg Injection might be necessary. A physician's advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Nayapime-TZ 1125mg Injection in patients with liver disease appears to present a low risk. Preliminary findings indicate dose modification may be unnecessary for this patient group. Physician consultation is recommended.
What if you forget to take Nayapime-TZ 1125mg Injection :
Omit a Nayapime-TZ 1125mg Injection dose? Seek medical advice immediately.
Facts to Know About Nayapime-TZ 1125mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Treatment Category | Drugs Against Infection |
3,018 People bought this recently